GLP hERG Screening at Metrion Biosciences Background
Metrion Biosciences Cardiac Safety Screening Icon Large 01 01

Discover the potential of GLP hERG Screening

High-quality, cost-effective compound screening for all your cardiac safety screening needs

Receive expert guidance from our dedicated team of Ion Channel Experts throughout your programme. Giving you, not only, the accurate and efficient study-related data you need in real time, but also interpretation, insight and advice to support your cardiac safety programme.

As an industry-leading CRO in Ion Channel Screening, we provide screening services against hERG using whole-cell patch-clamp electrophysiology.

Our GLP hERG screening services have been audited and approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and are performed in accordance with the FDA best-practice guidelines. We offer high-quality, cost-effective compound screening for all your cardiac safety screening needs.

What would you like to achieve today?

Choosing the right partner

As a dedicated ion channel CRO, we have extensive experience of providing high-quality biology services for ion channel targets. We are able to do this in a cost-effective and timely manner that dovetails with your own drug discovery timelines.

Our team offers:

  • Exceptional ion channel electrophysiology and drug discovery expertise
  • A team of experienced cell biologists to create novel cell lines
  • High-quality, cost-effective compound screening
  • Detailed characterisation of lead compounds in a range of high-quality assays
  • Translational services including confirmation of efficacy in stem cell and other phenotypic models 
  • Rapid reporting and data interpretation by highly experienced ion channel scientists

We are located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs.

Our state-of-the-art laboratories at Granta Park house high-quality facilities for native and engineered cell line and induced pluripotent stem cell culture. We have a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capabilities and laboratory data management and reporting systems. 

Our customers range from large pharmaceutical companies and established entities within the life sciences industry to smaller specialist businesses, charities, academics and start-ups looking to validate, develop or de-risk ion channel modulators as they progress towards a nomination for clinical development.

Find out more about how we can support you today.

Metrion Biosciences New HQ
GLP hERG Screening at Metrion Biosciences

Metrion’s Ion Channel Screening Resource Library

Videos and Presentations
Application notes and resources